DiaCarta
In Brief This Week: Pacific Biosciences, Macrogen, Dovetail Genomics, Bionano Genomics, More
News items for the week of Sept. 30, 2024.
DiaCarta Radiation Toxicity Liquid Biopsy Test Deployed in Florida Cancer Treatment Response Project
DiaCarta's RadTox cell-free DNA test will be used throughout Florida as part of a $1 million research project financed by the Florida Cancer Innovation Fund.
DiaCarta, OncoAssure Collaborate on Prostate Cancer LDT Launch
The firms said that DiaCarta's laboratory facilities in California will be used to validate the prostate cancer assay for a commercial launch.
DiaCarta, Hopkins MedTech Partner to Offer LDT and IVD Validation Services
The companies aim to fill an unmet need by shepherding diagnostic companies through regulatory and clinical lab validation processes.
DiaCarta SPAC Merger Scuttled on Allegations of Wrongdoing
DiaCarta said it received notice that special purpose acquisition company HH&L Acquisition was ending the business combination agreement signed in October 2022.
Oct 14, 2022
DiaCarta to go Public Through SPAC Merger
Aug 30, 2021
Mar 23, 2020
DiaCarta SARS-CoV-2 Test Kit Receives CE Mark
Feb 12, 2018
DiaCarta Raises $45M in Series B Funding
Feb 21, 2017